Table 1.
Patient characteristics.
| Total Number of Patients n = 103 | ||
|---|---|---|
| Age Median Age (Range/Min–Max) 52 Years (26–84) |
||
| Total | % | |
| Histology | ||
| Ductal | 99 | 96% |
| Lobular | 2 | 2% |
| Other | 2 | 2% |
| Menopausal Status | ||
| Pre-menopausal | 41 | 40% |
| Post-menopausal | 62 | 60% |
| Tumor Size | ||
| T1 | 23 | 22% |
| T2 | 65 | 63% |
| T3 + T4 | 15 | 15% |
| Nodal Status | ||
| Negative | 45 | 44% |
| Positive | 54 | 52% |
| Unknown | 4 | 4% |
| Stage | ||
| IA | 8 | 7% |
| IB | 49 | 48% |
| IC | 10 | 10% |
| IIA | 1 | 1% |
| IIB | 26 | 25% |
| IIC | 7 | 7% |
| IIIC | 2 | 2% |
| Ki-67 Pre-treatment | ||
| Ki-67 Median (Range) | 40% (5–90%) | |
| ≥40% | 51 | 50% |
| 15–39% | 37 | 35% |
| <15% | 13 | 13% |
| Unknown | 2 | 2% |
| Molecular subtype | ||
| Luminal A | 9 | 9% |
| Luminal B | 23 | 22% |
| HER-2 Positive | 18 | 18% |